Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription 15.07.2024 1 Arch Pediatr 1 Arch Virol 1 BMC Pediatr 4 Clin Infect Dis 1 Indian Pediatr 1 J Infect 2 J Infect Dis 5 JAMA 2 Lancet 1 Minerva Pediatr (Torino) 1 N Engl J Med 1 Nat Med 2 Pediatr Infect Dis J 1 Pediatrics 6 PLoS One 1 Proc Natl Acad Sci U S A 15 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Pediatr

1. CEUPPENS F, Meyts I, Bossuyt X, De Boeck K, et al
   Pneumococcal antibody response in children with recurrent respiratory tract infections: A descriptive study.
   Arch Pediatr. 2024;31:293-298.
   PubMed         Abstract available
   
   

   
   Arch Virol

2. LUO J, Zhang M, Ye Q, Gao F, et al
   A synthetic TLR4 agonist significantly increases humoral immune responses and the protective ability of an MDCK-cell-derived inactivated H7N9 vaccine in mice.
   Arch Virol. 2024;169:163.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

3. DADRAS O, Suwanbamrung C, Jafari M, Stanikzai MH, et al
   Prevalence of stunting and its correlates among children under 5 in Afghanistan: the potential impact of basic and full vaccination.
   BMC Pediatr. 2024;24:436.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

4. EDOSA M, Jeon Y, Gedefaw A, Hailu D, et al
   Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023.
   Clin Infect Dis. 2024;79.
   PubMed         Abstract available
   
   
5. HUSSEN M, Worku Demlie Y, Edosa M, Kebede M, et al
   Ethiopia National Cholera Elimination Plan 2022-2028: Experiences, Challenges, and the Way Forward.
   Clin Infect Dis. 2024;79.
   PubMed         Abstract available
   
   
6. PARK SE, Gedefaw A, Hailu D, Jeon Y, et al
   Coverage of Two-Dose Preemptive Cholera Mass Vaccination Campaign in High-Priority Hotspots in Shashemene, Oromia Region, Ethiopia.
   Clin Infect Dis. 2024;79.
   PubMed         Abstract available
   
   
7. BORJA-TABORA C, Fernando L, Lopez Medina E, Reynales H, et al
   Immunogenicity, safety, and efficacy of a tetravalent dengue vaccine in children and adolescents: an analysis by age group.
   Clin Infect Dis. 2024 Jul 12:ciae369. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Indian Pediatr

8. KUMAR P, Vashishtha VM
   Recent Surge in Mumps Cases in India: Will the Introduction of the MMR Vaccine Prevent Future Outbreaks?
   Indian Pediatr. 2024;61:695.
   PubMed        
   
   

   
   J Infect

9. WANG B, Mohammed H, Andraweera P, McMillan M, et al
   Vaccine effectiveness and impact of meningococcal vaccines against gonococcal infections: A systematic review and meta-analysis.
   J Infect. 2024 Jul 8:106225. doi: 10.1016/j.jinf.2024.106225.
   PubMed         Abstract available
   
   

   
   J Infect Dis

10. CHIME N, Anspach B, Jain V, Laajalahti O, et al
    Phase 3 Study Assessing Lot-to-lot Consistency of RSVPreF3 Vaccine and its Immune Response, Safety, and Reactogenicity When Co-administered with FLU-D-QIV.
    J Infect Dis. 2024 Jul 5:jiae342. doi: 10.1093.
    PubMed         Abstract available
    
    
11. GALAFA B, Chikaonda T, Kudowa E, Sichone S, et al
    Natural carriage of Streptococcus pneumoniae is associated with increased experimental pneumococcal carriage but reduced conjugate vaccine efficacy in a human challenge model.
    J Infect Dis. 2024 Jul 10:jiae341. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    JAMA

12. HARRIS E
    Symptoms After COVID-19 Vaccination Tied to Higher Antibody Levels.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12231.
    PubMed        
    
    
13. RUBIN R
    Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.10992.
    PubMed        
    
    
14. 
    The Conquest of Yellow Fever.
    JAMA. 2024;332:175.
    PubMed        
    
    
15. HARRIS E
    WHO: As Mpox Outbreaks Continue, Cases May Be Underestimated.
    JAMA. 2024;331:2070.
    PubMed        
    
    
16. SCRUGGS-WODKOWSKI EA, Malani PN, Linder KA
    Therapies to Decrease Severe Respiratory Syncytial Virus Illness.
    JAMA. 2024;331:2127-2128.
    PubMed        
    
    

    
    Lancet

17. ADEPOJU P
    African mpox surges show lack of vaccine access.
    Lancet. 2024;404:18.
    PubMed        
    
    
18. HO A, Galgut O, Faustini S, Peters N, et al
    Implications of suboptimal measles immunity in UK health-care workers.
    Lancet. 2024 Jun 26:S0140-6736(24)01011-0. doi: 10.1016/S0140-6736(24)01011.
    PubMed        
    
    

    
    Minerva Pediatr (Torino)

19. ARETI S, Parrillo M, Baker L, Meszaros A, et al
    Multisystem inflammatory syndrome in children: an evolving understanding of a syndrome amid the inflammatory continuum.
    Minerva Pediatr (Torino). 2024;76:545-555.
    PubMed         Abstract available
    
    

    
    N Engl J Med

20. SALMON DA, Orenstein WA, Plotkin SA, Chen RT, et al
    Funding Postauthorization Vaccine-Safety Science.
    N Engl J Med. 2024;391:102-105.
    PubMed        
    
    

    
    Nat Med

21. XU H, Zou K, Dent J, Wiens KE, et al
    Author Correction: Enhanced cholera surveillance to improve vaccination campaign efficiency.
    Nat Med. 2024 Jul 9. doi: 10.1038/s41591-024-03176.
    PubMed        
    
    

    
    Pediatr Infect Dis J

22. XIAO G, Zhu T, Wang Z, Xie X, et al
    Pentavalent Rotavirus Vaccine Coverage and Trends in Rotavirus Detection Before and After This Vaccination in Chengdu, China.
    Pediatr Infect Dis J. 2024 Jul 2. doi: 10.1097/INF.0000000000004441.
    PubMed         Abstract available
    
    
23. LEE ES, Choe YJ, Choe SA, Gwak ES, et al
    Relative Effectiveness of the NVX-CoV2373 Vaccine Compared With the BNT162b2 Vaccine in Adolescents.
    Pediatr Infect Dis J. 2024 Jul 3. doi: 10.1097/INF.0000000000004463.
    PubMed         Abstract available
    
    

    
    Pediatrics

24. KLEIN NP, Wiesner A, Bautista O, Group T, et al
    Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine.
    Pediatrics. 2024 Jul 9:e2023064693. doi: 10.1542/peds.2023-064693.
    PubMed         Abstract available
    
    

    
    PLoS One

25. ZEGEYE AF, Mekonen EG, Tekeba B, Alemu TG, et al
    Spatial distribution and determinants of measles vaccination dropout among under-five children in Ethiopia: A spatial and multilevel analysis of 2019 Ethiopian demographic and health survey.
    PLoS One. 2024;19:e0305393.
    PubMed         Abstract available
    
    
26. OLANI KUTA A, Dida N
    Covid-19 vaccine hesitancy and its predictors among diabetic patients on follow-up at public hospitals in Nekemte Town, Western Ethiopia.
    PLoS One. 2024;19:e0305200.
    PubMed         Abstract available
    
    
27. MASUM MHU, Wajed S, Hossain MI, Moumi NR, et al
    An mRNA vaccine for pancreatic cancer designed by applying in silico immunoinformatics and reverse vaccinology approaches.
    PLoS One. 2024;19:e0305413.
    PubMed         Abstract available
    
    
28. AL-RASHDAN RA, Ta'an W, Mukattash T, Williams B, et al
    Maternal skepticism regarding children's vaccination in Jordan: Investigating the knowledge, attitude, and adherence.
    PLoS One. 2024;19:e0305209.
    PubMed         Abstract available
    
    
29. TAREKE AA, Tewabe Ayelign A, Yewodiaw TK, Shiferaw EW, et al
    Retention rate of vaccination card and its associated factors among vaccinated children aged 12 horizontal line 23 months in Ethiopia: Multilevel logistic regression analysis.
    PLoS One. 2024;19:e0306421.
    PubMed         Abstract available
    
    
30. MAHARLOUEI N, Hosseinpour P, Erfani A, Shahriarirad R, et al
    Correction: Factors associated with reluctancy to acquire COVID-19 vaccination: A cross-sectional study in Shiraz, Iran, 2022.
    PLoS One. 2024;19:e0307336.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

31. HU Z, Lopez-Munoz AD, Kosik I, Li T, et al
    Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays.
    Proc Natl Acad Sci U S A. 2024;121:e2310421121.
    PubMed         Abstract available
    
    

    
    Vaccine

32. BANG JY, Kim YJ, Seo YJ, Hong SH, et al
    Reduced cell-mediated immune response in hyperglycemic NOD mice following influenza vaccination.
    Vaccine. 2024 Jul 8:S0264-410X(24)00757-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
33. KORCHINSKI I, Marquez C, McClymont E, Av-Gay G, et al
    Maternal-infant transfer of SARS-CoV-2 antibodies following vaccination in pregnancy: A prospective cohort study.
    Vaccine. 2024 Jul 8:S0264-410X(24)00785-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
34. WACHINGER J, Renosa MDC, Endoma V, Landicho-Guevarra J, et al
    Routines, disruptions, revised decisions: A biographical analysis of vaccination trajectories among Filipino caregivers.
    Vaccine. 2024 Jul 6:S0264-410X(24)00736-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
35. ARAUJO-CHAVERON L, Olivier C, Pellissier G, Bouvet E, et al
    Analyzing the 7C psychological antecedents of vaccine acceptance throughout the COVID-19 pandemic among healthcare sector workers in France: A repeated cross-sectional study (CappVac-Cov).
    Vaccine. 2024 Jul 6:S0264-410X(24)00744-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
36. LANIECE DELAUNAY C, Melo A, Maurel M, Mazagatos C, et al
    Corrigendum to "Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023-January 2024" [Vaccine 42(19) (2024)].
    Vaccine. 2024 Jul 5:S0264-410X(24)00730-8. doi: 10.1016/j.vaccine.2024.
    PubMed        
    
    
37. NOWALK MP, Smith KJ, Raviotta JM, Wateska A, et al
    Cost-effectiveness of recombinant influenza vaccine compared with standard dose influenza vaccine in adults 18-64 years of age.
    Vaccine. 2024 Jul 5:S0264-410X(24)00748-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
38. MESHRAM R, Kolte B, Gacche R
    Reverse vaccinology approach for identification of epitopes from E1 protein as peptide vaccine against HCV: A proof of concept.
    Vaccine. 2024 Jul 5:S0264-410X(24)00747-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
39. JIMENEZ-SEPULVEDA N, Gras-Valenti P, Chico-Sanchez P, Castro-Garcia JM, et al
    Effectiveness of mRNA booster doses in preventing infections and hospitalizations due to SARS-CoV-2 and its dominant variant over time in Valencian healthcare workers, Spain.
    Vaccine. 2024;42:4011-4021.
    PubMed         Abstract available
    
    
40. JITENDER, Vikram Kumar B, Singh S, Verma G, et al
    Mammalian cell expressed recombinant trimeric spike protein is a potent vaccine antigen and confers near-complete protection against SARS-CoV-2 infection in Hamster.
    Vaccine. 2024 Jul 8:S0264-410X(24)00740-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
41. SANCHEZ-GONZALEZ G, Luna-Casas G, Mascarenas C, Macina D, et al
    Corrigendum to "Pertussis in Mexico from 2000 to 2019: A real-world study of incidence, vaccination coverage, and vaccine effectiveness" [Vaccine 41(41) (2023) 6105-6111].
    Vaccine. 2024 Jul 8:S0264-410X(24)00726-6. doi: 10.1016/j.vaccine.2024.
    PubMed        
    
    
42. ZOU M, Lei C, Huang D, Liu L, et al
    Application of plant-derived products as adjuvants for immune activation and vaccine development.
    Vaccine. 2024 Jul 9:S0264-410X(24)00756-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
43. WEITZMAN ER, Pierce SE, Blakemore LM, Murdock A, et al
    Need for strategic communications and stakeholder engagement to advance acceptability of an overdose preventing vaccine targeting fentanyl.
    Vaccine. 2024 Jul 10:S0264-410X(24)00722-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
44. LAMBACH P, Silal S, Sbarra AN, Koh M, et al
    Corrigendum to "Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February-1 March 2024" [Vaccine 42(15) (2024) 3379-3383].
    Vaccine. 2024 Jul 11:S0264-410X(24)00743-6. doi: 10.1016/j.vaccine.2024.
    PubMed        
    
    
45. SARTORI AL, Buffarini R, Machado da Silva A, Amaral de Andrade Leao O, et al
    Child COVID-19 vaccine uptake among participants of the 2015 Pelotas (Brazil) Birth Cohort Study.
    Vaccine. 2024 Jul 11:S0264-410X(24)00746-1. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
46. GHARPURE R, Longley AT, Takamiya M, Hidle A, et al
    Typhoid conjugate vaccine perceptions and coverage among children and adults: Findings from a post-campaign coverage survey - Harare, Zimbabwe, 2019.
    Vaccine. 2024 Jul 10:S0264-410X(24)00727-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.